These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27068267)

  • 1. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
    Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
    J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
    Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
    Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
    Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
    Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.
    Moreira JM; da Silva AN; Marciano Vieira ÉL; Teixeira AL; Kummer AM; Simões E Silva AC
    Pediatr Nephrol; 2019 Feb; 34(2):349-352. PubMed ID: 30374604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
    J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
    Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
    Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural damage in diabetic nephropathy is associated with TNF-α system activity.
    Fernández-Real JM; Vendrell J; García I; Ricart W; Vallès M
    Acta Diabetol; 2012 Aug; 49(4):301-5. PubMed ID: 22042131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of sTNFR1 and BNP Levels with Diminished Estimated Glomerular Filtration Rate in Type 2 Diabetic Egyptian Patients.
    Mokhtar ER; M E; Hassan MA; Abou-ELHassan HA; Alanany MG; Hasuna MA
    Egypt J Immunol; 2018 Jan; 25(1):57-69. PubMed ID: 30242998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
    Chang LH; Chang TT; Chu CH; Huang CC; Lin LY
    Clin Chim Acta; 2024 May; 558():117880. PubMed ID: 38555050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
    Martin WP; Tuohy C; Doody A; Jackson S; Canavan RJ; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    Sci Rep; 2020 Sep; 10(1):14852. PubMed ID: 32908199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
    Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Tumor Necrosis Factor Receptor Type 1 Levels Exhibit A Stronger Association With Renal Outcomes Than Traditional Risk Factors in Chinese Subjects With Type 2 Diabetes Mellitus.
    Chang LH; Hwu CM; Lin YC; Huang CC; Won JGS; Chen HS; Lin LY
    Endocr Pract; 2020 Oct; 26(10):1115-1124. PubMed ID: 33471713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.
    Niewczas MA; Ficociello LH; Johnson AC; Walker W; Rosolowsky ET; Roshan B; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):62-70. PubMed ID: 19073786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
    Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
    Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuria.
    Miyazawa I; Araki S; Obata T; Yoshizaki T; Morino K; Kadota A; Ugi S; Kawai H; Uzu T; Nishio Y; Koya D; Haneda M; Kashiwagi A; Maegawa H
    Diabetes Res Clin Pract; 2011 May; 92(2):174-80. PubMed ID: 21288590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes.
    Doody A; Jackson S; Elliott JA; Canavan RJ; Godson C; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    J Diabetes Complications; 2018 Jan; 32(1):95-99. PubMed ID: 29122448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy.
    Zhang Y; Ruan Y; Zhang P; Wang L
    J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating TNF receptor 2 is closely associated with the kidney function in non-diabetic Japanese subjects.
    Kurashina T; Nagasaka S; Watanabe N; Yabe D; Sugi N; Nin K; Hosokawa M; Nomura Y; Fukushima M; Nakai Y; Nishimura F; Taniguchi A
    J Atheroscler Thromb; 2014; 21(7):730-8. PubMed ID: 24717758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.